ENDIA

Last updated
Environmental Determinants of Islet Autoimmunity (ENDIA) Study
ENDIA study logo Logo of the ENDIA study.tif
ENDIA study logo
ENDIA Study summary
Administering Institution University of Adelaide
Recruitment target1400
Eligibility criteriaUnborn babies or babies less than 6 months of age with a first-degree relative with type 1 diabetes (e.g. mother, father or sibling). Prior to birth the pregnant mother is enrolled in the study for investigation. After birth study participation transfers to the baby.
Participating statesSA, WA, NSW, Vic, QLD
Principal InvestigatorProfessor Jennifer Couper
http://www.endia.org.au

The Environmental Determinants of Islet Autoimmunity (ENDIA) Study is an Australian prospective pregnancy cohort study investigating the environmental triggers responsible for the autoimmune process that leads to type 1 diabetes. The study is led by Professor Jennifer Couper from the University of Adelaide in South Australia with collaborators from the Walter and Eliza Hall Institute, Royal Melbourne Hospital, Monash University and Monash Medical Centre in Victoria, the University of NSW and the Children's Hospital at Westmead, the Royal Hospital for Women and St. George's Hospital in NSW, the University of Queensland and Mater Health Services in Queensland, and the University of Western Australia and Princess Margaret Hospital for Children in Western Australia.

Contents

The aim of the ENDIA Study is to identify environmental factors and gene-environment interactions that contribute to and protect against the development of islet autoimmunity and progression to type 1 diabetes in children genetically at-risk. The study will follow 1,400 infants with a first-degree relative with type 1 diabetes prospectively from early pregnancy into childhood to investigate relationships between prenatal and postnatal environmental factors, and the development of islet autoimmunity and subsequent type 1 diabetes. ENDIA will evaluate the microbiome, nutrition, bodyweight/composition, metabolome-lipidome, insulin resistance, innate and adaptive immune function and viral infections. A systems biology approach will integrate multi-omics analyses to explore hypotheses and mechanisms underlying the development of islet autoimmunity.

The protocol for the ENDIA Study was published in BMC Pediatrics in 2013. [1]

Funding

The ENDIA Study is funded by the National Health and Medical Research Council (NHMRC) [2] of Australia, The Leona M. and Harry B. Helmsley Charitable Trust and the JDRF. [3]

Related Research Articles

Denise Louise Faustman is an American physician and medical researcher. An associate professor of medicine at Harvard University and director of the Immunobiology Laboratory at Massachusetts General Hospital, her work specializes in diabetes mellitus type 1 and other autoimmune diseases. She has worked at Massachusetts General Hospital in Boston since 1985.

<span class="mw-page-title-main">Birth weight</span> Weight of a human baby at birth

Birth weight is the body weight of a baby at their birth. The average birth weight in babies of European and African descent is 3.5 kilograms (7.7 lb), with the normative range between 2.5 and 4.0 kilograms. On average, babies of Asian descent weigh about 3.25 kilograms (7.2 lb). The prevalence of low birth weight has changed over time. Trends show a slight decrease from 7.9% (1970) to 6.8% (1980), then a slight increase to 8.3% (2006), to the current levels of 8.2% (2016). The prevalence of low birth weights has trended slightly upward from 2012 to the present.

JDRF is a nonprofit 501(c)(3) organization that funds type 1 diabetes (T1D) research, provides a broad array of community and activist services to the T1D population and actively advocates for regulation favorable to medical research and approval of new and improved treatment modalities. It was initially founded as the JDF, the Juvenile Diabetes Foundation. It later changed its name to the Juvenile Diabetes Research Foundation and is now known as JDRF.

<span class="mw-page-title-main">Type 1 diabetes</span> Form of diabetes mellitus

Type 1 diabetes (T1D), formerly known as juvenile diabetes, is an autoimmune disease that originates when cells that make insulin are destroyed by the immune system. Insulin is a hormone required for the cells to use blood sugar for energy and it helps regulate glucose levels in the bloodstream. Before treatment this results in high blood sugar levels in the body. The common symptoms of this elevated blood sugar are frequent urination, increased thirst, increased hunger, weight loss, and other serious complications. Additional symptoms may include blurry vision, tiredness, and slow wound healing. Symptoms typically develop over a short period of time, often a matter of weeks if not months.

Health impact assessment (HIA) is defined as "a combination of procedures, methods, and tools by which a policy, program, or project may be judged as to its potential effects on the health of a population, and the distribution of those effects within the population."

Automated insulin delivery systems are automated systems designed to assist people with insulin-requiring diabetes, by automatically adjusting insulin delivery in response to blood glucose levels. Currently available systems can only deliver a single hormone—insulin. Other systems currently in development aim to improve on current systems by adding one or more additional hormones that can be delivered as needed, providing something closer to the endocrine functionality of the pancreas.

The Environmental Determinants of Diabetes in the Young is a longitudinal study examining the environmental causes of Type 1 diabetes (T1D), formerly known as juvenile diabetes. The study follows children at high genetic risk for T1D from birth to 15 years of age.

The Joondalup Family Health Study (JFHS) will be an extensively characterized, community-based cohort study, which will investigate the complex interplay of environmental, lifestyle and genetic components that affect the risk of common conditions such as asthma, heart disease and diabetes. The Study will take place in Joondalup, Western Australia and will have a strong focus on families and the health of both children and adults.

Sandra Eades is a Noongar physician, researcher and professor, and the first Aboriginal medical practitioner to be awarded a Doctorate of Philosophy in 2003. As of March 2020 she is Dean of Medicine at Curtin University.

John Barthelow Classen is an American immunologist and anti-vaccinationist. He received his M.D. from the University of Maryland, Baltimore in 1988, his M.B.A. from Columbia University in 1992 and obtained his medical license in October 1997. He is best known for publishing research concluding that vaccines, in particular the Hib vaccine, cause insulin-dependent diabetes mellitus, a hypothesis he proposed based on experiments he conducted on mice in 1996. His views are disputed and considered unverified.

<span class="mw-page-title-main">Josephine Forbes</span> Australian scientist

Josephine Forbes is an Australian scientist specialising in the study of glycation and diabetes. She has been studying diabetes since 1999 and has worked at Royal Children's Hospital, University of Melbourne and Baker Heart and Diabetes Institute in Melbourne Australia. Since 2012 she has led the Glycation and Diabetes team at Mater Research which is a world-class medical research institute based at South Brisbane, and part of the Mater Group. Josephine is program leader for Mater's Chronic Disease Biology and Care theme, building greater understanding of the biological basis of a broad range of chronic diseases, and developing preventative strategies and innovative treatments to improve patient outcomes. Josephine and her team focus on how advanced glycation contributes to the pathogenesis of diabetes and its complications such as kidney disease.

V. Ramankutty is an Indian health economist, and epidemiologist, currently research director of Amala Cancer Research Centre, Amala Institute of Medical Sciences, Thrissur and an emeritus professor at the Sree Chitra Tirunal Institute for Medical Sciences and Technology. He is the son of former Chief Minister of Kerala, C. Achutha Menon.

Louise Maple-Brown is an Australian endocrinologist. She is a clinical researcher at the Royal Darwin Hospital, serving as the hospital's Head of Endocrinology and as NHMRC Practitioner Fellow with the Menzies School of Health Research at Charles Darwin University. She leads a clinical research program within the Wellbeing and Preventable Chronic Diseases division of Menzies with a focus on diabetes in Indigenous Australians and provides clinical diabetes services to urban and remote Northern Territory communities.

<span class="mw-page-title-main">Pregnancy Outcome Prediction study</span>

The Pregnancy Outcome Prediction (POP) Study is a prospective cohort study of 4,512 women who have never given birth, recruited at the Rosie Hospital between January 2008 and July 2012.

<span class="mw-page-title-main">Arba Minch General Hospital</span> Public hospital in Arba Minch, Southern Nations, Nationalities, and Peoples Region, Ethiopia

Arba Minch General Hospital is a public hospital located in Arba Minch town, Ethiopia. It is one of the general hospitals in SNNPR region of Gamo Zone. It has a bed capacity for 200 patients.

Valsamma Eapen is a chair of infant, child and adolescent psychiatry at UNSW Sydney. She is a fellow of the Royal Australian and New Zealand College of Psychiatrists, and the Royal College of Psychiatrists, UK.

<span class="mw-page-title-main">Cuilin Zhang</span> Chinese epidemiologist and physician-scientist

Cuilin Zhang is a Chinese-American epidemiologist and physician-scientist researching the roles of genetic and environmental factors in the pathogenesis of gestational diabetes, type 2 diabetes, and obesity and health consequences of these complications. Zhang is a senior investigator and acting chief of the epidemiology branch at the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

Xiaobin Wang is an American molecular epidemiologist. She is the Zanvyl Krieger Professor in Children's Health at Children's Memorial Institute and director of the Center on the Early Life Origins of Disease at the Johns Hopkins Bloomberg School of Public Health.

George Stephen Eisenbarth was an American diabetologist who specialized in type 1 diabetes. He helped to establish the autoimmune basis of the disease.

Annettee Olivia Nakimuli is a Ugandan obstetrician, gynecologist, medical researcher, academic and academic administrator. Since 17 February 2021, she serves as the Dean of Makerere University School of Medicine, the oldest medical school in East Africa. She concurrently serves as the Head of Department of Obstetrics and Gynecology at the same medical school, a role she has served in since 2016. She is also the President of the East, Central and Southern Africa College of Obstetrics and Gynecology.

References

  1. Penno MAS; Couper JJ; Craig ME; Colman PG; Rawlinson WD; Cotterill AM; Jones TW; ENDIA Study Group; Harrison LC (Aug 14, 2013). "Environmental determinants of islet autoimmunity (ENDIA): a pregnancy to early life cohort study in children at-risk of type 1 diabetes". BMC Pediatrics. 13 (1): 124. doi: 10.1186/1471-2431-13-124 . PMC   3751791 . PMID   23941366.
  2. National Health and Medical Research Council. "Project Grants for Funding Commencing 2012" (PDF).
  3. JDRF. "JDRF Funded Research". Archived from the original on 2014-03-14. Retrieved 2014-03-13.